Clinical trial
A Study to Evaluate the Safety and Effectiveness of FK778 in Liver Transplant…
NCT00451932 · Astellas Pharma Inc, Industry · Completed
Key facts
| NCT number | NCT00451932 |
|---|---|
| Title | A Study to Evaluate the Safety and Effectiveness of FK778 in Liver Transplant Patients |
| Official title | A Multicentre, Randomised, Double-Blind, Tacrolimus Dual Therapy-Controlled, Parallel Group, Multiple Oral Dose Study to Evaluate the Safety, Tolerability, Efficacy and Pharmacokinetics of FK778 in Liver Transplant Patients Receiving Standard Tacrolimus (FK506) and Steroids Therapy |
| Lead sponsor | Astellas Pharma Inc, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Liver Transplantation |
| Intervention type | Drug |
| Interventions | FK778 |
| Enrollment | 303 |
| Start date | Oct 1, 2002 |
| Primary completion | Sep 1, 2005 |
| Completion | Sep 1, 2005 |
| First posted | Mar 26, 2007 |
| Last update posted | Apr 17, 2008 |
| Countries | Austria, Belgium, Canada, Czechia, France, Germany, Hungary, Italy, Netherlands, Spain, Switzerland, United Kingdom |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: